Neural stem cell–derived small extracellular vesicles ameliorate disease progression in the SOD1 G93A murine model of amyotrophic lateral sclerosis
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlag013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Yalan Wan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University First Hospital, Beijing, 100034, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Extracellular Vesicles, Neural Stem Cells. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project, Brain Science and Brain-like Intelligence Technology, National Science and Technology Major Project.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that primarily affects motor neurons leading to muscle weakness, paralysis, and ultimately, respiratory failure. Extracellular vesicles (EVs) facilitate intercellular communication by mimicking the functions of their parent cells. In this study, we found that repeated administration of neural stem cell-derived extracellular vesicles (NSC-derived EVs) improved motor performance and provided protection to lumbar motor neurons, the neuromuscular junctions, and muscle morphology in the SOD1 G93A transgenic mouse model of ALS. Furthermore, by analyzing the RNA-sequencing of muscle specimens from ALS-SOD1 patients, we demonstrated that the rescue effects of NSC-derived EVs might be linked to the p53 pathway. Compared to the PBS control treatment group, both TP53 and the p53 upregulated modulator of apoptosis (PUMA) were downregulated in the spinal cord of mice treated with NSC-derived EVs. These data provide additional knowledge for the promising use of NSC-derived EVs as a potential therapy for ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Peking University First Hospital, Beijing, 100034, China.
- Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.
- Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, 100083, China.
- iRegene Therapeutics Co., Ltd., Chengdu, 610200, China.
- Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, 100034, China.
- Rare Diseases Medical Center, Peking University First Hospital, Beijing, 100034, China.
Förderung
- Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project
- Brain Science and Brain-like Intelligence Technology
- National Science and Technology Major Project
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
- High Quality Clinical Research Project of Peking University First Hospital
- Yicheng Foundation
Zitieren
APA
Wan, Y., Gao, C., Li, J., Luan, M., Lu, Y., Wang, J., Yang, B., Zheng, J., Yuan, Y., Wei, J., Wang, Z., & Deng, J. (2026). Neural stem cell–derived small extracellular vesicles ameliorate disease progression in the SOD1 G93A murine model of amyotrophic lateral sclerosis. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlag013
Vancouver
Wan Y, Gao C, Li J, Luan M, Lu Y, Wang J, et al. Neural stem cell–derived small extracellular vesicles ameliorate disease progression in the SOD1 G93A murine model of amyotrophic lateral sclerosis. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlag013
BibTeX
@article{Wan2026,
author = {Wan, Yalan and Gao, Chao and Li, Jieyu and Luan, Mingyue and Lu, Yuxuan and Wang, Jiaxin and Yang, Biyu and Zheng, Jie and Yuan, Yun and Wei, Jun and Wang, Zhaoxia and Deng, Jianwen},
title = {Neural stem cell–derived small extracellular vesicles ameliorate disease progression in the SOD1 G93A murine model of amyotrophic lateral sclerosis},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlag013}
}
EUVIMED